Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Excitotoxic models for neurodegenerative disorders.

R Schwarcz, A C Foster, E D French

    Life Sciences
    |July 2, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Parenteral penicillin apparatus.

    The Pharmaceutical journal·2010
    Same author

    Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.

    Peptides·2007
    Same author

    Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells.

    Neuropharmacology·2006
    Same author

    A photometric redshift of z = 6.39 +/- 0.12 for GRB 050904.

    Nature·2006
    Same author

    Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexia.

    Peptides·2005
    Same author

    Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala.

    Neuroscience·2004

    Excitotoxins, like quinolinic acid, are neuroactive amino acids implicated in neurodegenerative diseases. Research explores their role in conditions such as Huntington's disease and epilepsy, suggesting potential therapeutic targets.

    Area of Science:

    • Neuroscience
    • Neurochemistry

    Background:

    • Excitatory amino acids exhibit neurotoxin properties relevant to neurodegenerative disorders.
    • Excitotoxins cause characteristic axon-sparing neuronal lesions, modeled by kainic and ibotenic acids.
    • Animal models of Huntington's disease and epilepsy resemble excitotoxin-induced brain damage.

    Purpose of the Study:

    • Investigate the role of endogenous excitotoxins in human neurodegenerative diseases.
    • Explore quinolinic acid, a tryptophan metabolite found in brain tissue, as a potential endogenous excitotoxin.
    • Elucidate the mechanisms of excitotoxicity and its link to neurodegenerative pathogenesis.

    Main Methods:

    • Intracerebral infusions of kainic and ibotenic acids in experimental animals.
    • Investigation of quinolinic acid's metabolic and synaptic disposition.

    Related Experiment Videos

  • Utilizing selective antagonists of acidic amino acid receptors to study excitotoxic mechanisms.

    • Main Results:

    • Morphological and biochemical changes in animal models mimic human neurodegenerative conditions.
    • Quinolinic acid identified as a promising endogenous excitotoxin candidate.
    • Selective receptor antagonists aid in understanding excitotoxicity.

    Conclusions:

    • Endogenous excitotoxins, particularly quinolinic acid, may play a role in human neurodegenerative disease pathogenesis.
    • Further research is needed to establish a definitive biochemical link between endogenous excitotoxins and human diseases.
    • Pharmacological blockade of excitotoxicity presents a potential novel therapeutic strategy for neurodegenerative disorders.